In particular, the G-allele genotype of PDGFRβ exon 19 SNP (rs246395), encountered in 58% of tumor samples from colorectal cancer patients, was associated with increased pathway activation and significantly poorer survival. Here, PDGFRB is linked to colorectal cancer.